Introduction

Whey proteins are used as common ingredients in various products including infant formulas, specialized enteral and clinical protein supplements, and sports nutrition products with the expectation of the therapeutic potential of whey proteins and peptides. Lactoferrin, one of the major whey proteins, is a red iron-binding protein present mainly in external secretions such as breast milk and in polymorphonuclear neutrophils. This protein probably plays an important role in the defense mechanism of mucosal surfaces, since in an iron-depleted state it has bacteriostatic properties (1). Lactoferrin is released from polymorphonuclear neutrophils on activation of these cells and its presence in body fluids is proportional to the flux of neutrophils (2-5).
A (6) (7) (8) . Lactoferrin has been found in significant amounts in human stomach resection specimens from patients with superficial or atrophic gastritis (9) . The iron uptake of Helicobacter pylori via a specific human lactoferrin receptor may play a role in the refractory iron deficiency anemia (10) (25/26) (13, 16, 17, (19) (20) (21) . 
small but important component of body iron is that bound to transferrin, the iron transport protein in plasma, and to lactoferrin. Lactoferrin may also regulate granulopoiesis. Helicobacter pylori gastric infection has emerged as a new cause of refractory iron deficiency anemia, unresponsive to iron therapy, and not attributable to the usual causes such as intestinal losses or poor intake, malabsorption or diversion of iron in the reticulo-endothelial system
of samples from patients with shigellosis and concluded that fecal lactoferrin is a useful marker for fecal leucocytes (4). Dai et al evaluated the relationship between fecal lactoferrin and intestinal inflammation including ulcerative colitis (UC, 42 active and 17 inactive), Crohn's disease (CD, 14 active and 5 inactive), 41 infectious bowel disease, 25 irritable bowel syndrome (IBS) and 34 healthy volunteers. Fecal lactoferrin was significantly higher in inflammatory bowel disease including infectious bowel disease than in IBS and healthy volunteers. It provides us with a valid method to discriminate between inflammatory and non-inflammatory bowel disease (12). Schoepfer et al also reported the overall accuracy of fecal lactoferrin for discriminating IBS from inflammatory bowel disease or other forms of colitis including infectious colitis (13). However, Ashraf et al concluded that fecal lactoferrin was not useful in differentiating inflamma
Lactoferrin in ascites
Ascites is the most common complication of cirrhosis in patients with liver disease. Ascitic fluid often becomes infected without any apparent intra-abdominal source of infection called spontaneous bacterial peritonitis (SBP). The prevalence of SBP in unselected in-patients ranges from 10% to 30% (23). The infection resolution is high with antibiotic therapy, although in-hospital mortality is still over 20% mainly in secondary to hepato-renal syndrome (24). The diagnosis of SBP is based on a manual count of ascitic fluid polymorphonuclear cells. This procedure is operatordependent and lysis of the cells during transport to the laboratory may lead to false negative results. The situations are similar to those in fecal leucocyte count. Furthermore, ascitic fluid culture is insensitive and leads to delays in diagnosis. Parsi et al assessed the utility of ascitic fluid lactoferrin for the diagnosis of SBP in a total
